Clinical Trials

Overview

About this study

The purpose of this study is to assess the levels of urate in urine samples of patients with autosomal dominant polycystic kidney disease (ADPKD). Investigate how different urinary urate levels are associated with the severity of the disease and patients’ demographics, comorbidities, and treatments.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Participating Mayo Clinic locations

More information